I’m predicting a bio renaissance now that the world’s seen how far biotechnology has come and what we’re capable of pulling off. Will’s right, it’s time to do this for every disease 
https://twitter.com/WillManidis/status/1338492672340873217 …
if I had to bet my career on anything, it would be that rate of new biotech formation will 100x within the decade. reaching the rate of founding as tech cos, while maintaining biotech size. The downstream effects of this are generational
-
-
I hope so and I think so too, but the big blocker is going to be scaling the # of good founders for bio companies…my ~contrarian take~ is that most bio founders just aren’t great relative to tech founders. probs cause academia excellence is nearly opposite of startup excellence
-
@celinehalioua
we will probably see very different (probably also more junior) Biotech founders - the rise in tech startups in the 2000s was AFAIK also not fueled by masses of CS professors leaving their groups. Exciting times ahead!
End of conversation
New conversation -
-
-
You’re rate limited by the pace of regulatory evolution. It’s like yelling fire in a crowded movie theater, the fire exit can only fit so many “innovators” through at one time.
-
Still lots of opportunity—and I’d argue diminishing returns for drugs are due to having picked most of the fruit using old tools (e.g. hypothesis-driven, PhD’s as pipetting robots)—but it’s a reason I tend to focus on picks & shovels or tx platforms rather than individual assets.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.